Brinton Pharmaceuticals receives Series B funding from India Alternatives
Brinton is focused on dermatology and has recently expanded into the paediatric dermatology & respiratory segments
Brinton…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin recalls over 18,000 bottles of antibiotic drug in US
The company is recalling the drug, Cefdinir, due to “complaint received of metal piece identified in the product bottle prior to…
Novartis India appoints Sanjay Murdeshwar as Vice Chairman and Managing Director
Murdeshwar will take over as Country President, Novartis India, to lead its pharma business, and as Managing Director of Novartis…
AstraZeneca’s drug showed reduced Chronic Kidney Disease progress in cases of type-2 diabetes
Forxiga, the drug, showed a 47 per cent reduction in the composite of kidney function decline, end-stage renal disease or renal…
US FDA makes 2 observations for Caplin’s sterile injectable site in Chennai
Caplin Point Laboratories said it believes these observations are procedural in nature and corrective and "preventive actions for…
25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI
While 17 out of the 18 companies are private, one is a public sector unit (PSU) - Indian Drugs and Pharmaceuticals Limited (IDPL)
Biocon’s biologics facilities in Bengaluru received GMP compliance certificate from EMA
The certification will enable the company to continue addressing the growing needs of patients in the EU markets
Univercells granted $14.3 mn to deliver affordable measles and rubella vaccines
The grant has been given by the Bill and Melinda Gates Foundation to increase the availability of measles and rubella (M&R)…
Sun Pharma announces Late-Breaking Phase 2 data showing potential of ILUMYA (tildrakizumab-asmn)
The drug has been designed to improve joint and skin symptoms of Psoriatic Arthritis. Over 71 per cent of patients treated with…
DRL to sell neurology branded products to Upsher-Smith Laboratories
Dr Reddy’s would sell its US and select territory rights for ZEMBRACE SYMTOUCH and TOSYMRATM, which are commercialized through its…
OPPI to host an event on ‘The Future of Supply Chain Management’
The event endeavours to explore the challenges of supply chain management through discussions on manufacturing, warehousing,…
Wockhardt’s bioequivalence centre at Aurangabad receives zero observations from US FDA
During the inspection, bioanalytical and quality systems of bioequivalence studies of Tamsulosin 0.4 mg capsules and Metoprolol ER…
Neelikon conferred with the ‘SME Elite 50’ award
The award is a recognition as one of the Best Entrepreneur in the SME sector in India
Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology
The drug-maker said that it would buy a newly established company owning the drug candidate for the treatment of primary…
Catalyst Pharma sues FDA over approval of cheaper rival drug
The lawsuit alleges that the approval of Ruzurgi, a rival drug from privately held Jacobus Pharma, violated provisions of FDA…
Oral Novo Nordisk diabetes drug poses no more heart risk than placebo: study
Patients with type 2 diabetics and either heart disease who received the drug semaglutide in pill form had a combined rate of…
New psoriasis drug study yields positive results: Dr Reddy’s
According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be…
Alembic Pharma’s approves NCDs up to Rs 300 crore
The company, which did not specify the reasons for raising funds, said it will issue NCDs in one or more tranches
US-China trade war presents Indian pharma industry with a unique opportunity, says GlobalData
According to the data analytics company, the Indian pharma market will increase from nearly US$ 30.8 bn in 2018 to more than US$…
Dr Vatsal Shah to lead Siro Clinpharm’s US operations
Dr Shah is currently the COO of Siro Clinpharm and will transition to the Global Chief Operating Officer’s role to lead this…